Immutep

• locale

  Australia

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.immutep.com/

Immutep is a clinical-stage biotechnology company that develops LAG-3 immunotherapy for cancer and autoimmune diseases. The company focuses on therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), which is involved in regulating the immune system.